Alliance to begin drug research in new lab by fall
The Life Sciences Core Technology Alliance, a consortium that includes Michigan's three largest research universities, plans by early fall to begin drug research at a new $18 million facility at Argonne National Labs in Lemont, Ill., a federal lab operated by the University of Chicago. The new lab will enable the alliance to access a high-energy light source that cost Argonne hundreds of millions of dollars to build, said John Oliver, vice president of the alliance and vice president for research at Wayne State University. The light source allows researchers to determine the molecular structure of large molecules very quickly and is primarily used in drug-treatment research. The consortium has made a 15-year commitment to conduct the research, Oliver said.